Bright JR, Lis RT, Ku AT, Terrigino NT, et al. PROSTATE-SPECIFIC Membrane Antigen Is a Biomarker for Residual Disease Following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer. J Urol 2022 Mar 1:101097JU0000000000002492. doi: 10.1097/JU.0000000000002492.
PMID: 35227084